StockData
Nuvectis Pharma, Inc. logo

Nuvectis Pharma, Inc. (NVCT) stock

NVCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$19.11−1.13 (-5.58%)

Close on Nov 16, 2026Market cap $622.63MP/E –Yield 0.00%

Nuvectis Pharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Nuvectis Pharma's enterprise value was $538.43M on Nov 11, 2026, against $124.55M a year earlier. Over the last 5 years it ranged from $25.21M to $584.61M, with a median of $129.84M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$538.43M+240.5%
2025Dec 31, 2025$158.14M+84.9%
2024Dec 31, 2024$85.54M-30.1%
2023Dec 29, 2023$122.31M+41.9%
2022Dec 30, 2022$86.18M–

More Nuvectis Pharma figures

See a number that looks wrong?